(Q39784872)

14 September 2017

A comparison between amantadine and bromocriptine using the stereotyped behaviour response test (SBR) in the rat (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A134898

6 May 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A134898

6 May 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90121-7

11 December 2022

author name string

H. Schnieden

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A134898

6 May 2022

B. Cox

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A134898

6 May 2022

language of work or name

English

0 references

publication date

1 September 1976

1 reference

full work available at URL

14 September 2017

https://api.elsevier.com/content/article/PII:0014299976901217?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90121-7

https://api.elsevier.com/content/article/PII:0014299976901217?httpAccept=text/plain

11 December 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90121-7

European Journal of Pharmacology

11 December 2022

published in

1 reference

14 September 2017

39

1 reference

14 September 2017

133-141

1 reference

14 September 2017

1

1 reference

Hypothermic action of bromocriptine

14 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90121-7

Bromocriptine in Parkinsonism.

11 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90121-7

Effect of ergot drugs on central 5-hydroxytryptamine neurons: evidence for 5-hydroxytryptamine release or 5-hydroxytryptamine receptor stimulation

11 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90121-7

Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons.

11 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90121-7

The 6-hydroxydopamine rotational model for the detection of dopamine agonist activity: reliability of effect from different locations of 6-hydroxydopamine

11 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90121-7

Amantadine and apomorphine: interactions on striatal dopamine receptors

11 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90121-7

Interactions of L-dopa and amantadine in patients with Parkinsonism

11 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90121-7

Effects of amantadine and L-dopa on apomorphine- and d-amphetamine-induced stereotyped behaviour in rats.

11 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90121-7

Amantadine tremor, a 5-hydroxytryptamine-mediated response?

11 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90121-7

Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats

11 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90121-7

Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.

11 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90121-7

Effects of amantadine and amphetamine on serotonin uptake and release by human blood platelets

11 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90121-7

11 December 2022

Identifiers

1 reference

14 September 2017

1 reference